miR-34a as a novel regulator of TGFβ signaling in GBM
Giannicola Genovese(The University of Texas MD Anderson Cancer Center), Lynda Chin(American Productivity and Quality Center), David L. Rimm(Yale University), Katherine Dunn(Cedars-Sinai Medical Center), Sharmistha Sarkar(The University of Texas MD Anderson Cancer Center), Lawrence N. Kwong(The University of Texas MD Anderson Cancer Center), Simona Colla(The University of Texas MD Anderson Cancer Center), Hongwu Zheng, James J. Collins(Broad Institute), Kunal Rai(The University of Texas MD Anderson Cancer Center), Ayla Ergün(Harvard University), Sachet A. Shukla(The University of Texas MD Anderson Cancer Center), Cameron Brennan(Memorial Sloan Kettering Cancer Center), Jianhua Zhang(XinHua Hospital), Yonghong Xiao, Hailei Zhang, Steven N. Quayle(CTI BioPharma (Italy)), Wolf R. Wiedemeyer(Cedars-Sinai Medical Center), Benito Campos(Technische Hochschule Mannheim), Papia Ghosh(Cedars-Sinai Medical Center), Chang‐Jiun Wu
Unknown
January 1, 2012
Cited by 0
Related Papers
The Somatic Genomic Landscape of Glioblastoma
|Cell|2013|5.2k
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
|Nature Genetics|2019|4.4k
Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity
|Cell|2015|4.2k